Precise Treatment System of Biliary Malignancies Based on Special Disease Database
NCT ID: NCT03499782
Last Updated: 2018-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000 participants
OBSERVATIONAL
2018-05-25
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer
NCT06276153
A Machine-learning Model to Predict Lymph Node Metastasis of Intrahepatic Cholangiocarcinoma
NCT06290739
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
NCT04078230
Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma
NCT03796819
Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma
NCT01862276
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be able to undergo surgery
* Undergoing radical surgery for biliary malignancy (R0 or R1 resection)
* Not complicated with other malignancy
* No other treatments before and during surgery, such as radiotherapy and chemotherapy.
Exclusion Criteria
* With distant metastasis (M1 phase)
* Incomplete follow-up data
* Died within 30 days after surgery.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital Xi'an Jiaotong University
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
The First Affiliated Hospital of Dalian Medical University
OTHER
Shanghai Zhongshan Hospital
OTHER
Southwest Hospital, China
OTHER
Tianjin Medical University Cancer Institute and Hospital
OTHER
Sun Yat-sen University
OTHER
Affiliated Hospital of North Sichuan Medical College
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Eastern Hepatobiliary Surgery Hospital
OTHER
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhaohui Tang
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhimin Geng, MD,PhD
Role: STUDY_DIRECTOR
the first affiliated hospital of xi'an Jiaotong univerisity
Peng Gong, MD,PhD
Role: STUDY_DIRECTOR
the first affiliated hospital of Dalian medical univerisity
Yu He, MD,PhD
Role: STUDY_DIRECTOR
Southwest Hospital, China
Shengping Li, MD,PhD
Role: STUDY_DIRECTOR
Cancer Institute and Hospital Affiliated to Sun Yat-sen University
Yinghe Qiu, MD,PhD
Role: STUDY_DIRECTOR
Eastern Hepatobiliary Surgery Hospital
Zhi Dai, MD,PhD
Role: STUDY_DIRECTOR
Shanghai Zhongshan Hospital
Tianqiang Song, MD,PhD
Role: STUDY_DIRECTOR
Tianjin Medical University Cancer Institute and Hospital
Yudong Qiu, MD,PhD
Role: STUDY_DIRECTOR
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Jianying Lou, MD,PhD
Role: STUDY_DIRECTOR
Second Affiliated Hospital, School of Medicine, Zhejiang University
Jingdong Li, MD,PdD
Role: STUDY_DIRECTOR
Affliated Hospital of North Sichuan Medical College
Wenlong Zhai, MD,PhD
Role: STUDY_DIRECTOR
The First Affiliated Hospital of Zhengzhou University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhaohui Tang
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XHEC-JDYXY-2018-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.